Cidofovir, also known as Vistide™, is a newer anti-viral drug originally developed for a different indication and now appearing to have value in the treatment of laryngeal papillomatosis. It is increasingly used as an adjunctive, off-label treatment for human papillomavirus infection in the larynx – that is, recurrent respiratory papillomatosis (RRP) or laryngeal papillomatosis.
Long-term Remission or even “cure” of RRP/Laryngeal Papilloma
RRP Cure? Or Just Long Term Remission?
What “Cured” this Case of RRP? Surgery? Cidofovir? The Patient’s Immune System? All Three?
Humility Before the HPV Virus—A Recurrence of Papillomas at Ten Years
HPV 18—High Risk Subtype
Vocal Cord Injection of Cidofovir
This video portrays a vocal cord injection of Cidofovir following the removal of a papilloma.